Study finds 5-year relative survival rate of 59.6 percent in lower-risk myelodysplastic syndromes
About 40 percent of patients with lower-risk myelodysplastic syndromes (LR-MDS) die of MDS within five years, according to a study published online Nov. 6 in the British Journal of Haematology.
Nov 23, 2022
0
2